Susvimo
NDC 50242-078 · Genentech, Inc.
Generic nameRanibizumab
Dosage formINJECTION, SOLUTION
RouteINTRAVITREAL
Active ingredient(s)RANIBIZUMAB
Strength100 mg/mL
Pharmacologic classVascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
Marketing categoryBLA
Packages
50242-078-12 — 1 VIAL in 1 CARTON (50242-078-12) / 1 mL in 1 VIAL
50242-078-55 — 1 VIAL in 1 CARTON (50242-078-55) / 1 mL in 1 VIAL
Billed under HCPCS
J2779 — Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg Medicare Part B payment limit (ASP + 6%): $74.80
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50242-080 — RANIBIZUMAB, 50242-082 — RANIBIZUMAB, 61314-624 — ranibizumab-eqrn, 61314-625 — ranibizumab-eqrn, 64406-019 — ranibizumab-nuna, 70114-440 — ranibizumab-eqrn, 70114-441 — ranibizumab-eqrn, 70710-2172 — ranibizumab-leyk, 70710-2173 — ranibizumab-leyk, 82667-018 — ranibizumab-nuna